JPRN-jRCT2031210549招募中未知
Special use-results survey of ENAROY Tablets(long-term use)
Patient Safety and Pharmacovigilance Dept.0 个研究点目标入组 1,500 人开始时间: 2022年1月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 1,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •(1) Patients using Enaroy for the first time for nephrogenic anemia
- •(2) Patients must provide informed consent before the start
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Special Drug Use-results Survey of RIONA Tablets (Pregnant Patients with Iron Deficiency Anemia)Iron deficiency anaemiaJPRN-jRCT2031210322Dept. and Pharmacovigilance Patient Safety100
已完成
Unknown
Special Drug Use-Results Survey of Onoacttachyarrhythmia, atrial fibrillation/atrial flutter in patients with cardiac dysfunctionJPRN-jRCT1080222572ONO PHARMACEUTICAL CO., LTD.800
招募中
不适用
Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Canceron-small cell lung cancerJPRN-jRCT2031210404Contact for Clinical Trial Information500
已完成
不适用
Special drug use-results survey on ERLEADA 60 mg Tablets (Long-term use in patients with non-distant metastatic castration-resistant prostate cancer)non-distant metastatic castration-resistant prostate cancerJPRN-UMIN000036808Janssen Pharmaceutical K.K.218
已完成
1 期
Study to Evaluate Different Extended Release (ER)-Formulations and Multiple Ascending Dosing of AZD3241HealthyNCT00914303AstraZeneca77